UK plans to ease lockdown



UMMATIMES - British Prime Minister Boris Johnson on Monday, April 5, 2021, announced that anyone living in the UK can test for the coronavirus up to two times a week. This policy was issued following the reopening of community activities and the ongoing corona virus vaccine immunization.

Prime Minister Johnson has drawn up plans to relax the rules in the next few months. By loosening the rules, Johnson plans to open the door to international traffic and open up the country's economy.

Britain is one of the countries worst hit by the coronavirus outbreak. So with the corona virus mass test, it is hoped that it can break the chain of spread and overcome Covid-19 cases without symptoms.

Britain's plan to relax the lockdown is in contrast to European countries which are tightening lockdowns to deal with rising positive cases of Covid-19. To that end, Britain's plan is a big boost in the midst of the Covid-19 pandemic.

"As we continue to make good progress in our vaccine program (the coronavirus vaccine), we plan to be careful about loosening the rules," said Johnson.

Meanwhile, Edward Argar, the junior Health Minister of England, said that the corona virus test kits will be sent to homes, offices or businesses. It can also be taken at pharmacies or corona virus testing centers.

"Society has done the right thing," said Argar.

With the increase in the number of people testing for the corona virus, it will help medical personnel track the transmission of the Covid-19 pandemic following the government's plan to gradually relax the lockdown after tightening rules for four months.

If nothing gets in the way, Prime Minister Johnson wants to open up retail, outdoor entertainment and beauty salons across the UK from April 12, 2021.

Meanwhile, the entry of travelers from outside the UK will use a 'traffic light' system based on the severity of infection in the country the traveler last visited and the traveler's coronavirus vaccine immunization status. The corona virus vaccine passport is currently in a trial period for mass use.